SMART-TRIAL Announces Partnership with MedTech Innovator, the Largest Medical Technology Accelerator in the World

Collaboration Demonstrates SMART-TRIAL’s Commitment to Innovation in Medical Technology

AALBORG, DENMARK — February 1, 2022 — SMART-TRIAL, the industry leader in Data Acquisition & Management systems built specifically for Medical Device & Diagnostics clinical investigations and registries, announced today its partnership with MedTech Innovator, the premier accelerator in the medical technology industry. MedTech Innovator matches healthcare industry leaders with innovative early-stage and emerging growth medtech companies for mentorship and support. Fifty startups will participate in the MedTech Innovator 2022 program, including 25 early-stage companies in the Accelerator cohort. This year, MedTech Innovator will award more than $500,000 in cash prizes and in-kind services.

SMART-TRIAL will work directly with the cohort companies and will also provide financial support to MedTech Innovator. The startups selected for the 2022 program will be exclusively featured at the two largest gatherings of industry leaders on the East and West coasts of the United States: The WSGR Medical Device Conference on June 17 in San Francisco and The MedTech Conference powered by AdvaMed taking place October 24-26 in Boston.

“SMART-TRIAL is committed to supporting leading-edge health innovations that aim to deliver optimal patient outcomes,” said Adam Steadman, Chief Commercial Officer – Americas & Asia, SMART-TRIAL. “We are excited to be a part of the MedTech Innovator ecosystem as one of its newest partners and provide strategic counsel and mentorship to startups seeking to bring novel technologies to global healthcare delivery systems.”

“With the support of our vast network of industry partners, MedTech Innovator identifies and advances the industry’s most promising medical technology and digital health companies to help ensure that their innovations successfully reach patients,” said Paul Grand, founder and CEO of MedTech Innovator. “Our partners and sponsors play an invaluable part in advancing innovation with their expertise and industry knowledge. We are pleased to welcome SMART-TRIAL as one of our newest partners and look forward to working together to achieve better patient outcomes and provide value to the healthcare system.”

SMART-TRIAL joins founding sponsors Johnson & Johnson and RCT Ventures, and annual program sponsors NIPRO Medical Corp., Asahi Intecc, BD, Edwards Lifesciences LLC, Dexcom, Fujikura Ltd., Jabil Healthcare, Olympus Medical Systems Group, W. L. Gore & Associates, Inc., Experien Group, now a part of Veranex, Greenlight Guru, Medmarc, Medical Technology Enterprise Consortium (MTEC), NAMSA, Oliver Healthcare Packaging, Proxima Clinical Research, Silicon Valley Bank, Three Bridges Management & Consulting, Velentium, and Ximedica, now a part of Veranex. The organization’s industry partners include AdvaMed, Health+Commerce, MedTech Strategist, and Wilson Sonsini Goodrich & Rosati.

READ FULL ARTICLE HERE

Previous
Previous

KGI’s Dr. Kiana Aran Receives NIH Funding to Help Set Quality Control Standards for CRISPR Therapies

Next
Next

Los Angeles Has More Tech Job Postings Than San Francisco